The Global Health Body Issues Concern Over Acute Scarcity of Weight-Loss Injections

Fewer than a tenth of individuals eligible to benefit from obesity jabs such as Wegovy have access to them, caution the global health agency as it issues its first recommendations on the drugs.

Considering more than one billion people worldwide currently living with obesity, it is calling for more widespread and fairer availability to this class of drugs.

Based on estimates, in excess of 2,000,000,000 are projected to be living with obesity by 2030 if no action is taken.

"The new guidelines recognises that obesity is a chronic disease that can be managed with thorough and continuous care," stated WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are key hurdles to widespread access to the injections that can assist patients in reducing considerable weight, explains the organization.

Weight-Loss Drug Supply Crisis

Even under the current most favorable scenario, the manufacturing of GLP-1 therapies could only cover about 100 million people – fewer than 10% of those who need them, as stated by the WHO.

The recommendation encourages nations and manufacturers to widen availability, via strategies including voluntary licensing.

The intellectual property rights on a key compound – the core component of a leading brand – is due to expire in multiple nations in 2026.

How Weight-Loss Injections Operate

The injections replicate a body's own hormone to reduce digestion speed, reduce hunger and increase satiety so individuals consume fewer calories.

People commonly begin shedding pounds after several weeks of beginning the regular doses.

Evidence points to users may put most of the weight back on within a year of halting the drug, when their normal appetite come back.

Being above a healthy weight elevates your risk for developing diseases, including diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity impacts people in all nations and was responsible for over three and a half million deaths worldwide in 2024, as per the health agency.